Position in ZLAB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$940
-$754 QoQ
Shares Held
50
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZLAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Advisory Services Network, LLC holds $24,653,003 across 166 Biotechnology names. ZLAB ranks #112 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
51,990 | $4,893,296 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,953 | $3,054,242 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,218 | $2,330,040 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,314 | $2,089,107 | |
| 5 | RPRX |
Royalty Pharma plc
|
33,855 | $1,624,023 | |
| 6 | EXEL |
Exelixis, Inc.
|
29,442 | $1,262,766 | |
| 7 | OCUL |
Ocular Therapeutix, Inc
|
138,897 | $1,176,456 | |
| 8 | WVE |
Wave Life Sciences Ltd.
|
144,950 | $1,050,887 |
All Filings in ZLAB
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $940 | 50 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $1,694 | 50 | Shares | Sole | 2025-11-18 | |
| 2023-12-31 | $1,366 | 50 | Shares | Sole | 2024-02-09 | |
| 2023-03-31 | $1,663 | 50 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $1,535 | 50 | Shares | Sole | 2023-02-13 | |
| 2020-12-31 | $0 | 0 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $3,243 | 39 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||